BTS
SRPT icon

BB&T Securities’s Sarepta Therapeutics SRPT Stock Holding History

BB&T Securities’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$294K Sell
3,879
-31
-0.8% -$3.66K ﹤0.01% 1331
2019
Q2 		$594K Buy
3,910
+20
+0.5% +$2.43K 0.01% 1025
2019
Q1 		$463K Buy
3,890
+332
+9% +$42.7K ﹤0.01% 1115
2018
Q4 		$388K Sell
3,558
-222
-6% -$27.8K ﹤0.01% 1077
2018
Q3 		$610K Sell
3,780
-1,010
-21% -$138K 0.01% 997
2018
Q2 		$633K Sell
4,790
-3,205
-40% -$302K 0.01% 978
2018
Q1 		$592K Buy
7,995
+2,286
+40% +$152K 0.01% 953
2017
Q4 		$317K Buy
+5,709
New +$302K ﹤0.01% 1166

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return